Rhonda M. Cooper‐DeHoff

13.3k total citations · 3 hit papers
195 papers, 7.2k citations indexed

About

Rhonda M. Cooper‐DeHoff is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Rhonda M. Cooper‐DeHoff has authored 195 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 126 papers in Cardiology and Cardiovascular Medicine, 70 papers in Endocrinology, Diabetes and Metabolism and 36 papers in Molecular Biology. Recurrent topics in Rhonda M. Cooper‐DeHoff's work include Blood Pressure and Hypertension Studies (94 papers), Hormonal Regulation and Hypertension (59 papers) and Pharmacogenetics and Drug Metabolism (32 papers). Rhonda M. Cooper‐DeHoff is often cited by papers focused on Blood Pressure and Hypertension Studies (94 papers), Hormonal Regulation and Hypertension (59 papers) and Pharmacogenetics and Drug Metabolism (32 papers). Rhonda M. Cooper‐DeHoff collaborates with scholars based in United States, Italy and United Kingdom. Rhonda M. Cooper‐DeHoff's co-authors include Carl J. Pepine, Eileen Handberg, Yan Gong, Julie A. Johnson, Franz H. Messerli, George L. Bakris, Anthony A. Bavry, Scott J. Denardo, C. Noel Bairey Merz and Julio D. Duarte and has published in prestigious journals such as JAMA, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Rhonda M. Cooper‐DeHoff

187 papers receiving 7.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Calcium Antagonist vs a Non–Calcium Antagonist Hypertension Treatment Strategy for Patients With Coronary Artery Disease

2003 859 citations Carl J. Pepine, Eileen Handberg et al. profile →
Tight Blood Pressure Control and Cardiovascular Outcomes Among Hypertensive Patients With Diabetes and Coronary Artery Disease

2010 445 citations Rhonda M. Cooper‐DeHoff, Yan Gong et al. profile →
The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 and Simvastatin-Induced Myopathy: 2014 Update

2014 301 citations Kelly E. Caudle, Rhonda M. Cooper‐DeHoff et al. Clinical Pharmacology & Therapeutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rhonda M. Cooper‐DeHoff United States	41	4.1k	1.9k	1.4k	992	958	195	7.2k
J. Malcolm O. Arnold Canada	49	6.2k 1.5×	2.2k 1.1×	5.4k 4.0×	941 0.9×	1.2k 1.2×	102	13.5k
J. Feely Ireland	51	2.5k 0.6×	1.1k 0.6×	1.3k 1.0×	830 0.8×	583 0.6×	255	7.8k
Brian F. Gage United States	55	9.7k 2.4×	1.7k 0.9×	1.9k 1.4×	4.2k 4.3×	1.3k 1.4×	180	17.4k
Željko Reiner Croatia	47	3.8k 0.9×	3.7k 1.9×	6.8k 5.0×	361 0.4×	1.5k 1.6×	265	13.3k
Janice Pogue Canada	42	14.7k 3.6×	2.5k 1.3×	2.0k 1.4×	294 0.3×	1.0k 1.1×	74	19.3k
Yan Gong United States	39	1.8k 0.4×	1.4k 0.7×	695 0.5×	758 0.8×	1.3k 1.3×	200	4.9k
C. Michael Stein United States	36	2.1k 0.5×	720 0.4×	658 0.5×	1.6k 1.6×	1.0k 1.1×	68	7.0k
Morris J. Brown United Kingdom	49	5.8k 1.4×	4.2k 2.2×	2.2k 1.7×	273 0.3×	1.8k 1.9×	198	10.1k
Michel Azizi France	45	4.4k 1.1×	2.7k 1.4×	1.3k 1.0×	167 0.2×	1.2k 1.2×	269	7.6k
Sandosh Padmanabhan United Kingdom	38	2.3k 0.6×	1.2k 0.6×	767 0.6×	132 0.1×	1.0k 1.1×	183	5.9k

Countries citing papers authored by Rhonda M. Cooper‐DeHoff

Since Specialization

Citations

This map shows the geographic impact of Rhonda M. Cooper‐DeHoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rhonda M. Cooper‐DeHoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rhonda M. Cooper‐DeHoff more than expected).

Fields of papers citing papers by Rhonda M. Cooper‐DeHoff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rhonda M. Cooper‐DeHoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rhonda M. Cooper‐DeHoff. The network helps show where Rhonda M. Cooper‐DeHoff may publish in the future.

Co-authorship network of co-authors of Rhonda M. Cooper‐DeHoff

This figure shows the co-authorship network connecting the top 25 collaborators of Rhonda M. Cooper‐DeHoff. A scholar is included among the top collaborators of Rhonda M. Cooper‐DeHoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rhonda M. Cooper‐DeHoff. Rhonda M. Cooper‐DeHoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Winterstein, Almut G., Matthew J. Gurka, Anne M. Libby, et al.. (2025). Disparities in Initial Antihypertensive Intensity by Sex, Race and Ethnicity in Newly Treated Patients With Hypertension. American Journal of Hypertension. 38(8). 560–569.

Eadon, Michael T., David W. Hein, Michael Asger Andersen, et al.. (2025). Clinical Pharmacogenetics Implementation Consortium Guideline for NAT2 Genotype and Hydralazine Therapy. Clinical Pharmacology & Therapeutics. 118(6). 1430–1436.

Lu, Yuan, Ellen C. Keeley, Rhonda M. Cooper‐DeHoff, et al.. (2024). Use of electronic health records to characterize patients with uncontrolled hypertension in two large health system networks. BMC Cardiovascular Disorders. 24(1). 497–497. 1 indexed citations

Cicali, Emily J., Elizabeth M. Eddy, Yan Gong, et al.. (2024). Implementation of a pharmacogenetic panel‐based test for pharmacotherapy‐based supportive care in an adult oncology clinic. Clinical and Translational Science. 17(7). e13890–e13890. 1 indexed citations

McDonough, Caitrin W., Steven M. Smith, Yan Gong, et al.. (2024). Integrated metabolomics analysis reveals mechanistic insights into variability in blood pressure response to thiazide diuretics and beta blockers. Clinical and Translational Science. 17(5). e13816–e13816. 1 indexed citations

Winterstein, Almut G., Matthew J. Gurka, Anne M. Libby, et al.. (2024). Initial Antihypertensive Prescribing in Relation to Blood Pressure Among Florida Medicaid and Medicare Recipients in the OneFlorida+ Research Consortium. Hypertension. 81(2). e7–e9.

Fontil, Valy, Madelaine Faulkner Modrow, Rhonda M. Cooper‐DeHoff, et al.. (2023). Improvement in Blood Pressure Control in Safety Net Clinics Receiving 2 Versions of a Scalable Quality Improvement Intervention: BP MAP A Pragmatic Cluster Randomized Trial. Journal of the American Heart Association. 12(3). e024975–e024975. 2 indexed citations

DeRemer, David L., Avirup Guha, Faraz S. Ahmad, et al.. (2023). Racial and Ethnic Differences in Cardiac Surveillance Evaluation of Patients Treated With Anthracycline‐Based Chemotherapy. Journal of the American Heart Association. 12(10). e027981–e027981. 6 indexed citations

Cooper‐DeHoff, Rhonda M., et al.. (2023). New Drugs Approved in 2022. The American Journal of Medicine. 136(6). 545–550. 5 indexed citations

10.

Armstrong, Nicole D., Vinodh Srinivasasainagendra, Alana Jones, et al.. (2022). Genetic Contributors of Efficacy and Adverse Metabolic Effects of Chlorthalidone in African Americans from the Genetics of Hypertension Associated Treatments (GenHAT) Study. Genes. 13(7). 1260–1260. 5 indexed citations

11.

Smith, Steven M., Almut G. Winterstein, Matthew J. Gurka, et al.. (2022). Initial Antihypertensive Regimens in Newly Treated Patients: Real World Evidence From the OneFlorida+ Clinical Research Network. Journal of the American Heart Association. 12(1). e026652–e026652. 14 indexed citations

12.

McDonough, Caitrin W., Steven M. Smith, Yan Gong, et al.. (2022). Influence of Genetic West African Ancestry on Metabolomics among Hypertensive Patients. Metabolites. 12(9). 783–783. 6 indexed citations

13.

Keeley, Ellen C., Yan Gong, Eileen Handberg, et al.. (2020). Attended vs unattended systolic blood pressure measurement: A randomized comparison in patients with cardiovascular disease. Journal of Clinical Hypertension. 22(11). 1987–1992. 7 indexed citations

14.

McDonough, Caitrin W., Steven M. Smith, Rhonda M. Cooper‐DeHoff, & William R. Hogan. (2019). Optimizing Antihypertensive Medication Classification in Electronic Health Record-Based Data: Classification System Development and Methodological Comparison. JMIR Medical Informatics. 8(2). e14777–e14777. 12 indexed citations

15.

Smith, Steven M., Matthew J. Gurka, Almut G. Winterstein, Carl J. Pepine, & Rhonda M. Cooper‐DeHoff. (2019). Incidence, prevalence, and predictors of treatment‐resistant hypertension with intensive blood pressure lowering. Journal of Clinical Hypertension. 21(6). 825–834. 17 indexed citations

16.

Borja‐Hart, Nancy, et al.. (2019). Atherosclerotic cardiovascular disease risk assessment and predictors of statin use in Filipino‐American Women. Journal of Clinical Pharmacy and Therapeutics. 44(4). 632–639. 2 indexed citations

17.

Smith, Steven M. & Rhonda M. Cooper‐DeHoff. (2018). Fixed-Dose Combination Amlodipine/Celecoxib (Consensi) for Hypertension and Osteoarthritis. The American Journal of Medicine. 132(2). 172–174. 13 indexed citations

18.

Smith, Steven M., Matthew J. Gurka, David A. Calhoun, et al.. (2018). Optimal Systolic Blood Pressure Target in Resistant and Non-Resistant Hypertension: A Pooled Analysis of Patient-Level Data from SPRINT and ACCORD. The American Journal of Medicine. 131(12). 1463–1472.e7. 13 indexed citations

19.

Cooper‐DeHoff, Rhonda M., et al.. (2018). 2017 Is Banner Year for Drug Approvals by the Food and Drug Administration. The American Journal of Medicine. 131(9). 1025–1033. 2 indexed citations

20.

McDonough, Caitrin W., Yan Gong, Sandosh Padmanabhan, et al.. (2013). Pharmacogenomic Association of Nonsynonymous SNPs in SIGLEC12 , A1BG , and the Selectin Region and Cardiovascular Outcomes. Hypertension. 62(1). 48–54. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact